ICI Conference to Exit: How Israeli Cardiology Innovation Became a Global Success
An article in Maariv reviews the ICI cardiology innovation conference, founded by Prof. Haim Lotan and Prof. Rafi Beyar, operating for three decades. The conference connects doctors, researchers, and entrepreneurs, enabling the presentation of technologies to international companies. The article details a series of exits by Israeli companies in the field, totaling $7 billion, acquired by giants such as Medtronic, Johnson & Johnson, and Edwards Lifesciences.
The ICI cardiology innovation conference, founded by Prof. Haim Lotan and Prof. Rafi Beyar, has been operating for over three decades and serves as a meeting point for doctors, researchers, and entrepreneurs. Its uniqueness lies in connecting clinical needs with technological solutions and providing a platform for young companies to present their developments to decision-makers in the global industry. The article reviews a series of notable exits by Israeli companies that presented at the conference, including Instent, Biosense, Ventor Technologies, MediGuide, PVT, Valtech, Corindus Vascular Robotics, Innovalve, V-Wave, Vectorius, CathWorks, and Sonivie, acquired by giants such as Medtronic, Johnson & Johnson, Edwards Lifesciences, Siemens Healthineers, and Boston Scientific. The total exit deals in the cardiovascular field amount to $7 billion. The conference is seen as a growth engine connecting medicine, technology, and capital.
ICI Conference to Exit: How Israeli Cardiology Innovation Became a Global Success